InspireMD (NSPR) Misses Q3 EPS by 1c

InspireMD (NASDAQ: NSPR) reported Q3 EPS of ($0.15), $0.01 worse than the analyst estimate of ($0.14). Revenue for the quarter came in at $1.6 million versus the consensus estimate of $1.5 million.

For earnings history and earnings-related data on InspireMD (NSPR) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• Adobe Systems (ADBE) Tops Q2 EPS by 14c, Offers Guidance
• InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)